Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.molcel.2011.08.011
DC FieldValue
dc.titleContext-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
dc.contributor.authorLee, S.T.
dc.contributor.authorLi, Z.
dc.contributor.authorWu, Z.
dc.contributor.authorAau, M.
dc.contributor.authorGuan, P.
dc.contributor.authorKaruturi, R.K.M.
dc.contributor.authorLiou, Y.C.
dc.contributor.authorYu, Q.
dc.date.accessioned2014-12-12T07:59:44Z
dc.date.available2014-12-12T07:59:44Z
dc.date.issued2011-09-02
dc.identifier.citationLee, S.T., Li, Z., Wu, Z., Aau, M., Guan, P., Karuturi, R.K.M., Liou, Y.C., Yu, Q. (2011-09-02). Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers. Molecular Cell 43 (5) : 798-810. ScholarBank@NUS Repository. https://doi.org/10.1016/j.molcel.2011.08.011
dc.identifier.issn10972765
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/116962
dc.description.abstractBoth EZH2 and NF-κB contribute to aggressive breast cancer, yet whether the two oncogenic factors have functional crosstalk in breast cancer is unknown. Here, we uncover an unexpected role of EZH2 in conferring the constitutive activation of NF-κB target gene expression in ER-negative basal-like breast cancer cells. This function of EZH2 is independent of its histone methyltransferase activity but requires the physical interaction with RelA/RelB to promote the expression of NF-κB targets. Intriguingly, EZH2 acts oppositely in ER-positive luminal-like breast cancer cells and represses NF-κB target gene expression by interacting with ER and directing repressive histone methylation on their promoters. Thus, EZH2 functions as a double-facet molecule in breast cancers, either as a transcriptional activator or repressor of NF-κB targets, depending on the cellular context. These findings reveal an additional mechanism by which EZH2 promotes breast cancer progression and underscore the need for developing context-specific strategy for therapeutic targeting of EZH2 in breast cancers. © 2011 Elsevier Inc.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.molcel.2011.08.011
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentBIOLOGICAL SCIENCES
dc.contributor.departmentGENOME INSTITUTE OF SINGAPORE
dc.description.doi10.1016/j.molcel.2011.08.011
dc.description.sourcetitleMolecular Cell
dc.description.volume43
dc.description.issue5
dc.description.page798-810
dc.description.codenMOCEF
dc.identifier.isiut000294593300014
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

212
checked on Aug 12, 2020

WEB OF SCIENCETM
Citations

211
checked on Aug 12, 2020

Page view(s)

93
checked on Aug 15, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.